Carbamazepine
NDC Package 29033-019-12
Package Information
Carbamazepine is used to prevent and control seizures. Marketed by Nostrum Laboratories, Inc., this product is identified by NDC 29033-019 and is authorized under FDA application ANDA076697.
Identification & Billing
- RxCUI: 200131 - carBAMazepine 300 MG 12HR Extended Release Oral Capsule
- RxCUI: 200131 - 12 HR carbamazepine 300 MG Extended Release Oral Capsule
- RxCUI: 200131 - carbamazepine 300 MG 12 HR Extended Release Oral Capsule
- RxCUI: 200133 - carBAMazepine 200 MG 12HR Extended Release Oral Capsule
- RxCUI: 200133 - 12 HR carbamazepine 200 MG Extended Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 29033 - Nostrum Laboratories, Inc.
- 29033-019 - Carbamazepine
- 29033-019-12 - 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 29033-019 - Carbamazepine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 29033-019-12 identifies a specific commercial package of 120 capsule, extended release in 1 bottle of Carbamazepine, labeled by Nostrum Laboratories, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nostrum Laboratories, Inc. on February 17, 2020. The current certification is valid through December 31, 2025.
What are the primary indications for this medication?
Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.
How is this Nostrum Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 29033001912. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.